Core Insights - Lexaria Bioscience Corp. will participate in the BIO International Convention in Boston from June 16-19, 2025, aiming to advance discussions with potential partners and investors [1][2] Company Overview - Lexaria is a global innovator in drug delivery platforms, specifically through its patented DehydraTECH® technology, which enhances drug absorption and reduces side effects [4] - The company holds 48 granted patents and has additional patents pending worldwide, showcasing a strong intellectual property portfolio [4] Event Participation - The BIO International Convention is the largest biotechnology convention globally, featuring over 1,500 exhibitors and 20,000 attendees, providing a platform for networking and collaboration [2] - Lexaria is arranging one-on-one meetings with corporate leaders in sectors such as weight loss, diabetes, and hypertension, with limited meeting slots still available [3]

AptarGroup (ATR) 2025 Conference June 04, 2025 02:00 PM ET Speaker0 Afternoon. I'm Dan Rizzo with Jefferies Equity Research. Presenting now is Aptar Group, and with us today is CEO, Stefan Tanda, and CFO, Vanessa Cano. There'll be a presentation, but there should be time at the end for questions. So with that, I will turn it over to Stefan. Thanks. Speaker1 Alright, Dan. Thanks for having us. It's my pleasure to introduce you to Aptar Group. It's, I think, our inaugural presence at this, conference. The rea ...